Publication | Closed Access

A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines

Cancer ImmunosurveillanceDash Family EnzymesPan InhibitorImmunologyImmunoeditingCell DeathImmune Checkpoint InhibitorAutoimmunityCombination TherapyImmunomodulationImmunotherapyMedicineRadiation OncologyTumor Microenvironment